UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors
Go back to UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 5.35 +0.03 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $7.27 | |||
| Open | $5.37 | 52 Week Low | $2.39 | |||
| Day High | $5.53 | P/E | N/A | |||
| Day Low | $5.28 | EPS | $-0.61 | |||
| Volume | 4,444,170 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,754,171 | |||||
| NOVARTIS AG (NYSE: NVS) | Delayed: 154.61 -2.18 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.79 | 52 Week High | $89.15 | |||
| Open | $156.47 | 52 Week Low | $69.84 | |||
| Day High | $157.34 | P/E | N/A | |||
| Day Low | $154.51 | EPS | $0.00 | |||
| Volume | 1,073,158 | |||||

